ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 431,04
-0,79%
Dow Jones
41 938,45
-1,63%
DAX
20 214,79
-0,51%
Brent Oil
79,285
0,00%
Bitcoin
94 359,29
-0,37%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. CSE

  6. Kal Minerals Corp (KAL) Cours

Kal Minerals Corp

Kal Minerals Corp (KAL)

Kalgoorlie Gold Mining Ltd
0,14
0,00
(0,00%)
Fermé 11 Janvier 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,14
Prix Achat
0,135
Prix Vente
0,40
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,14 Plage de 52 semaines 0,14
Clôture Veille
0,14
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

KAL Dernières nouvelles

Plus de nouvelles

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

20 Septembre 2007
PR Newswire (US)

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

29 Août 2007
PR Newswire (US)

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

11 Août 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

09 Août 2007
PR Newswire (US)

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

08 Août 2007
PR Newswire (US)

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

07 Août 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

25 Juin 2007
PR Newswire (US)

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

08 Juin 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, May 24 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs for the treatment of cancer and inflammatory diseases, announced today...

24 Mai 2007
PR Newswire (US)

Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal

History of Atiprimod Appears in Genetic Engineering & Biotechnology News NEW YORK, May 15 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical...

15 Mai 2007
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.140.140.1400CS
4000.140.140.1400CS
12000.140.140.1400CS
26000.140.140.1400CS
52000.140.140.1400CS
156000.140.140.1400CS
2600.06750.080.160.0816150.12165007CS

KAL - Frequently Asked Questions (FAQ)

What is the current Kal Minerals share price?
The current share price of Kal Minerals is $ 0,14
What is the 1 year trading range for Kal Minerals share price?
Kal Minerals has traded in the range of $ 0,14 to $ 0,14 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SPSSweet Poison Spirits Inc
$ 0,13
(225,00%)
580k
SQXSquatex Energy and Ressources Inc
$ 0,01
(100,00%)
1 000
TGLDTorrent Gold Inc
$ 0,10
(66,67%)
17k
CHGXChitogenX Inc
$ 0,025
(66,67%)
214,5k
HROHero Innovation Group Inc
$ 0,15
(50,00%)
12,53k
EPIC1CM Inc
$ 0,255
(-49,00%)
9,5k
SKURSekur Private Data Ltd
$ 0,02
(-33,33%)
669,03k
RFRRenforth Resources Inc
$ 0,01
(-33,33%)
57k
MYTCMyndTec Inc
$ 0,20
(-33,33%)
1 000
TAATTAAT Global Alternatives Inc
$ 0,17
(-26,09%)
5,5k
PKKPeak Fintech Group Inc
$ 0,05
(-9,09%)
4,96M
QIMCQuebec Innovative Materials Corp
$ 0,11
(4,76%)
3,27M
CVGRCity View Green Holdings Inc
$ 0,01
(33,33%)
2,35M
CATCAT Strategic Metals Corporation
$ 0,005
(0,00%)
2,33M
PREVPreveCeutical Medical Inc
$ 0,035
(16,67%)
1,71M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

CSE
KAL
Kal Minerals
TG
TII
Texas Instruments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés